Well focus on the gut, our immune system and the brain, or more simply whats called the Gut-Immune-Brain axis

Your GP can: Assess your current weight, BMI, and metabolic health to determine clinical need Review existing treatment options that are currently licensed and available in the UK, which may include orlistat, naltrexone/bupropion (Mysimba), semaglutide 2.4 mg (Wegovy approved by the MHRA for weight management and subject to NICE guidance on eligibility, service setting, and treatment duration), and tirzepatide (Mounjaro check current MHRA and NICE status at the time of reading, as licensing and commissioning arrangements may have been updated) Discuss eligibility for NHS Tier 3 or Tier 4 specialist weight management services , in line with NICE guidance on obesity management, where pharmacotherapy is used as an adjunct to structured lifestyle intervention Signpost you to relevant clinical trials via the Be Part of Research portal or ClinicalTrials.gov if you wish to explore participation in retatrutide research It is important to approach information about investigational medicines with appropriate caution

Oncology populations have not been formally studied
The role vitamin B12 plays in the production of myelin, the substance that forms the protective sheath around the nerve fibers, might be the most significant of vitamin B12s many health advantages from the perspective of nerve health
Research indicates that even modest weight loss can lead to improvements in metabolic health, such as better blood sugar control, reduced blood pressure, and lower cholesterol levels